Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 60505-0130-5 - (Carbidopa and Levodopa)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 60505-0130
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: Carbidopa and Levodopa
Active Ingredient(s): 25; 250    mg/1; mg/1 & nbsp;   Carbidopa and Levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 60505-0130
Labeler Name: Apotex Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077120
Marketing Category: ANDA
Start Marketing Date: 20081009

Package Information of Carbidopa and Levodopa

Package NDC: 60505-0130-5
Package Description: 500 TABLET in 1 BOTTLE (60505-0130-5)

NDC Information of Carbidopa and Levodopa

NDC Code 60505-0130-5
Proprietary Name Carbidopa and Levodopa
Package Description 500 TABLET in 1 BOTTLE (60505-0130-5)
Product NDC 60505-0130
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carbidopa and Levodopa
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20081009
Marketing Category Name ANDA
Labeler Name Apotex Corp.
Substance Name CARBIDOPA; LEVODOPA
Strength Number 25; 250
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information